Penzberg, Germany

Alexander Knaupp

USPTO Granted Patents = 5 

Average Co-Inventor Count = 8.3

ph-index = 1


Location History:

  • Wackersberg, DE (2022)
  • Penzberg, DE (2023)

Company Filing History:


Years Active: 2022-2025

Loading Chart...
5 patents (USPTO):

Title: Alexander Knaupp: Innovator in Antibody Technology

Introduction

Alexander Knaupp is a notable inventor based in Penzberg, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target specific proteins for therapeutic purposes. With a total of 5 patents to his name, Knaupp's work is paving the way for advancements in medical treatments.

Latest Patents

One of Knaupp's latest patents involves antibodies that bind to CD3 and CD19. This invention is crucial for activating T cells, which play a vital role in the immune response. The patent also covers polynucleotides encoding these antibodies, as well as vectors and host cells that incorporate such polynucleotides. Furthermore, the invention outlines methods for producing these antibodies and their applications in treating various diseases.

Career Highlights

Knaupp is currently associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical and biotechnology sectors. His work at the company has allowed him to focus on innovative solutions that address critical health challenges. His expertise in antibody technology has positioned him as a key player in the industry.

Collaborations

Some of Knaupp's notable coworkers include Anne Freimoser-Grundschober and Ralf Hosse. Their collaborative efforts contribute to the advancement of research and development in the field of biotechnology.

Conclusion

Alexander Knaupp's contributions to antibody technology exemplify the impact of innovation in the medical field. His patents and ongoing work continue to inspire advancements that may lead to effective treatments for various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…